The National Institutes of Health has appointed Eric Dishman as the new director for a national research program that seeks to build up precision medicine efforts.
Dishman, formerly a vice president at Intel and a fellow at its health and life sciences group, brings nearly 20 years of experience to the Precision Medicine Initiative Cohort Program, NIH Director Francis Collins said in a statement published Monday.
The new program director will lead the agency’s efforts to expand its health and disease treatment capabilities and advance the PMI research study that he has worked on in the previous year as a member of the PMI working group.
He has collected experience as a social scientist, researcher, entrepreneur, business leader, patient advocate, policy advocate and thought leader and has founded research and policy programs on telehealth, personal health records and behavioral markers for Alzheimer’s, Parkinson’s and other diseases, Collins wrote.
The PMI Cohort Program looks to build a national precision medicine research cohort comprised of one million or more volunteer participants.